Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1942 Jan 31;75(2):165–178. doi: 10.1084/jem.75.2.165

THE LS-ANTIGEN OF VACCINIA

II. ISOLATION OF A SINGLE SUBSTANCE CONTAINING BOTH L- AND S-ACTIVITY

Theodore Shedlovsky 1, Joseph E Smadel 1
PMCID: PMC2135242  PMID: 19871174

Abstract

Virus-free filtrate, obtained from suspensions of vaccine virus-infected dermal pulp of rabbits and rich in the soluble substances of vaccinia, was shown to contain four distinct components in electrophoresis experiments. Electrophoretic and serological observations served as a guide in developing a method for separating these components from one another. This method depended upon changes in the solubilities of the components with alterations of pH. Three of the four components appeared to be serologically inert when tested with anti-vaccinia sera. All of the L- and S-activity was found to be associated with a single component which was electrically homogeneous at several values of pH and which was homogeneous in the ultracentrifuge. This single substance, designated as LS-antigen, precipitates in equal titers with optimal amounts of L- and of S-antibody and is completely removed from solution by absorption with either antibody. The LS-antigen of vaccinia appears to be a protein molecule with two antigenically distinct parts, L and S. Heating modifies the L-portion in such a manner that the substance no longer precipitates with L-antibody; this degraded antigen still combines with L-antibody, as is shown by inhibition tests, and still precipitates with S-antibody. Similarly, treatment with heat and dilute alkali modifies the S-portion of LS-antigen so that it combines but does not precipitate with S-antibody; and at the same time all recognizable immunological properties of the L-portion are destroyed.

Full Text

The Full Text of this article is available as a PDF (782.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Craigie J., Wishart F. O. STUDIES ON THE SOLUBLE PRECIPITABLE SUBSTANCES OF VACCINIA : II. THE SOLUBLE PRECIPITABLE SUBSTANCES OF DERMAL VACCINE. J Exp Med. 1936 Oct 31;64(5):819–830. doi: 10.1084/jem.64.5.819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Longsworth L. G., Shedlovsky T., Macinnes D. A. ELECTROPHORETIC PATTERNS OF NORMAL AND PATHOLOGICAL HUMAN BLOOD SERUM AND PLASMA. J Exp Med. 1939 Sep 30;70(4):399–413. doi: 10.1084/jem.70.4.399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Parker R. F. IMMUNOLOGICAL STUDIES OF A HEAT-STABLE SUBSTANCE ISOLATED FROM TISSUES INFECTED WITH VACCINE VIRUS. J Exp Med. 1938 Feb 28;67(3):361–367. doi: 10.1084/jem.67.3.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Parker R. F., Rivers T. M. IMMUNOLOGICAL AND CHEMICAL INVESTIGATIONS OF VACCINE VIRUS : VI. ISOLATION OF A HEAT-STABLE, SEROLOGICALLY ACTIVE SUBSTANCE FROM TISSUES INFECTED WITH VACCINE VIRUS. J Exp Med. 1937 Jan 31;65(2):243–249. doi: 10.1084/jem.65.2.243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Smadel J. E., Rivers T. M. THE LS-ANTIGEN OF VACCINIA : I. INHIBITION OF L- AND S-ANTIBODIES BY SUBSTANCES IN TREATED VACCINE DERMAL FILTRATE. J Exp Med. 1942 Jan 31;75(2):151–164. doi: 10.1084/jem.75.2.151. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES